Authors: Lindqvist, PG Zoller, B Dahlback, B

Citation: Pg. Lindqvist et al., Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden - An evolutionary advantage?, THROMB HAEM, 86(4), 2001, pp. 1122-1123

Authors: Zoller, B Redman-Muller, I Nanda, I Guttenbach, M Dosch, E Schmid, M Zoorob, R Jungwirth, C

Citation: B. Zoller et al., Sequence comparison of avian interferon regulatory factors and identification of the avian CEC-32 cell as a quail cell line, J INTERF CY, 20(8), 2000, pp. 711-717

Authors: Farber, L Stratz, T Bruckle, W Spath, M Pongratz, D Lautenschlager, J Kotter, I Zoller, B Peter, HH Neeck, G Alten, R Muller, W

Citation: L. Farber et al., Efficacy and tolerability of tropisetron in primary fibromyalgia - a highly selective and competitive 5-HT3 receptor antagonist, SC J RHEUM, 29, 2000, pp. 49-54

Authors: Zoller, B de Frutos, PG Hillarp, A Dahlback, B

Citation: B. Zoller et al., Thrombophilia as a multigenic disease, HAEMATOLOG, 84(1), 1999, pp. 59-70

Authors: Norlund, L Holm, J Zoller, B Ohlin, AK

Citation: L. Norlund et al., The Ala(25)-Thr mutation in the thrombomodulin gene is not frequent in Swedish patients suffering from ischemic heart disease, THROMB HAEM, 82(4), 1999, pp. 1367-1368

Authors: Holm, J Hillarp, A Zoller, B Erhardt, L Berntorp, E Dahlback, B

Citation: J. Holm et al., Factor V Q(506) (resistance to activated protein C) and prognosis after acute coronary syndrome, THROMB HAEM, 81(6), 1999, pp. 857-860